Präparat: REKAMBYS® 600 mg/ -900 mg Depot-Injektionssuspension
Rote Liste®
Search in Rote Liste®
All databases
REKAMBYS® 600 mg/ -900 mg Depot-Injektionssuspension
This content is only available to registered users
If you’re visiting this website the first time and would like to test the database free of charge for ten days, then click here to register once. After you’ve registered, log in with your user name and password.You’re already registered with DrugBase and would like to test the database free of charge for ten days without any further commitment? Then log in here with your access data and select the database you wish to test.
Hauptgruppe
83: Virustatika
> 83.1: Interna
> 83.1.B: Chemisch definierte Virustatika
> 83.1.B.1: Antiretrovirale Mittel
> 83.1.B.1.1: Einzelstoffe
>
83.1.B.1.1.4: Nicht-nucleosidische Reverse-Transkriptase-Inhibitoren (NNRTI)
...
...
Hersteller
Zentrale Zulassung
...
Anwendungsgebiete
...
Gegenanzeigen
...
Anwendungsbeschränkungen
...
Schwangerschaft
...
Stillzeit
...
Nebenwirkungen
...
Wechselwirkungen
...
Intoxikationen
...
Warnhinweise
...
Hinweise
...
Dosierung
...
Copyright
© Rote Liste® Service GmbH, ROTE LISTE® 2021
